Alteogen (196170) failed to escape weakness on the 23rd, ahead of the weekend, slipping below the 230,000-won level. Following the previous day's decline on the 22nd, the stock posted consecutive losses, and attention is now focused on whether its share price can find a catalyst for a rebound going forward.

Alteogen closed at 222,000 won that day. Looking at its recent price trend, the stock has failed to secure clear upward momentum and has not breached the 300,000-won level this month. The key question is whether buying interest will flow back in the short term and whether the stock can break out of its downward trend and shift the mood.

Despite the weak share price, Alteogen currently retains its position as the top market-cap stock on the KOSDAQ. As a large-cap biotech stock representing the KOSDAQ, its future price movements are expected to continue drawing market attention. How news related to technology transfers and business performance will affect investor sentiment is also worth watching.

The KOSDAQ index also failed to avoid weakness that day. The KOSDAQ closed at 751.69 on the 23rd, down 12.41 points (-1.62%) from the previous trading day. With downward pressure appearing across the KOSDAQ market, Alteogen, the top stock by market cap, also declined.

Ultimately, the key question is whether Alteogen can reclaim the 230,000-won level and lay the groundwork for a rebound. With the stock having failed to surpass the 300,000-won level this month, all eyes are on whether the share price will slide further or attempt a rebound in the new trading week.

[This article is not intended as investment advice; the final judgment and responsibility for investments rest with the investor.]